Where does TearSolutions's cap table come from?

Share classes are assembled from certificates of incorporation, priced-round filings, and disclosures across TearSolutions's 11 recorded funding rounds.

Premier Alternatives

TearSolutions

Charlottesville, VA · Founded 2013 · Privately Held (backing)

Developer of a peptide therapy designed for the treatment of signs and symptoms of dry eye in primary sjögren's syndrome patients. TearSolutions is based in Charlottesville, VA and was founded in 2013. Its last reported valuation was $280 million in Nov 2024. It has raised $44.1 million across 11 recorded rounds; the latest was a $517,000 seed round in Oct 2025.

Last reported valuation

$280.0M

Oct 2026

Priced at

—

Total raised

$44.1M

Last round

Seed Round

Oct 2025

Cap table — not yet on record

TearSolutions's share-class structure hasn't surfaced in our sources yet. Cap tables are assembled from certificates of incorporation, round filings, and disclosures as they land.

Pro members can request priority coverage with a 48-hour turnaround.

Free account

More of TearSolutions with a free account

·The complete investor list: 13 names
·Watch TearSolutions: the Monday email on marks, rounds and moves

Create free account

No card required

Membership and data by Private Market View

Frequently asked about TearSolutions

Where does TearSolutions's cap table come from?: Share classes are assembled from certificates of incorporation, priced-round filings, and disclosures across TearSolutions's 11 recorded funding rounds.